Inspiration Healthcare Group PLC Mello Healthcare Presentation 25th May 2021

TIDMIHC

Inspiration Healthcare Group PLC

20 May 2021

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Group" and the "Company")

Inspiration Healthcare Group plc to present at Mello Healthcare; Invest in Good Health on Tuesday 25(th) May 2021, via Zoom Webinar

Inspiration Healthcare (AIM: IHC), the global medical technology company, is pleased to announce that the Company will be attending Mello Healthcare; Invest in Good Health on Tuesday 25(th) May 2021 taking place from 6pm to 9.30pm. Neil Campbell, CEO and Jon Ballard, CFO, will be presenting and taking questions from participants. If you would like to attend, you can register here for the event using code SHVIP75 .

For further information on the Mello London conference, please visit the event website https://melloevents.com/

Enquiries:

 
 Inspiration Healthcare Group plc          Tel: [phone] 
  Neil Campbell, Chief Executive Officer 
  Jon Ballard, Chief Financial Officer 
 Nominated Adviser & Broker                Tel: [phone] 
  Cenkos Securities plc 
  Mark Connelly 
  Stephen Keys 
                                          ------------------- 
 Cadogan PR                                Tel: [phone] 
  Alex Walters 
  [e-mail] 
                                          ------------------- 
 

About the Group:

www.inspirationhealthcaregroup.plc.uk

Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in critical care & operating theatres with a focus on neonatal care. The Company provides high-quality, innovative products to patients around the world which help to improve patient outcomes, and it actively invests in innovative product opportunities and disruptive technologies.

The Group currently consists of three companies: Inspiration Healthcare Ltd, SLE Ltd and Viomedex Ltd and under these brands the Group sells neonatal intensive care and operating theatre equipment around the world through a network of distributors into over 75 countries. Products range from highly sophisticated capital equipment through to single use disposables all of which can help improve outcomes of extremely sick patients.

In the UK and Ireland the Group offers direct sales for most of its products supported by Technical Service offering on site and return to base repair and maintenance along with 24/7 emergency hire of equipment and long term lease arrangements for its own brand products. The Group also acts as a distributor for 3rd party companies that wish to access the UK and the Republic of Ireland's health systems using the Group's sales and service expertise and knowledge of these healthcare providers. The therapy areas in which we distribute products such as Infusion, Respiratory and Developmental Care add value to our product portfolio.

The Group invests in growth through its Research and Development function holding numerous patents on its technology and has strong links with academic Key Opinion Leaders around the world and supports clinical research in the field of neonatal intensive care.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word "Reach" in the source column of the News Explorer pages of London Stock Exchange's website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NRAURAORARUVUAR

(END) Dow Jones Newswires

May 20, 2021 09:15 ET (13:15 GMT)